Definitive Healthcare Corp. (DH) Insider Trading Activity

NASDAQ$1.235+0.07 (5.98%)
Market Cap
$124.89M
Sector
Healthcare
Industry
Medical—Healthcare Information Services
Rank in Sector
512 of 849
Rank in Industry
18 of 29

DH Insider Trading Activity

DH Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
–
Sells
$0
0
–

Related Transactions

About Definitive Healthcare Corp.

Definitive Healthcare Corp. (DH), operating through its various subsidiaries, offers specialized commercial intelligence solutions for the U.S. healthcare industry. The company's services furnish essential data on healthcare providers and their activities, enabling clients to navigate critical business processes, from the early stages of product development to strategic market entry planning and effective sales and marketing execution. Its sophisticated platform incorporates sixteen distinct intelligence modules. These modules are designed to …

Insider Activity of Definitive Healthcare Corp.

Over the last 12 months, insiders at Definitive Healthcare Corp. have bought $0 and sold $0 worth of Definitive Healthcare Corp. stock.

On average, over the past 5 years, insiders at Definitive Healthcare Corp. have bought $2.62M and sold $19.08M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 450,000 shares for transaction amount of $5.19M was made by Krantz Jason Ronald (director) on 2022‑11‑07.

List of Insider Buy and Sell Transactions, Definitive Healthcare Corp.

2024-12-03SaleMoschella WilliamChief Product & Tech Officer
45,000
0.039%
$4.70
$211,500
-19.16%
2023-08-24SaleSEA VII Management, LLCdirector
6,656
0.0058%
$9.39
$62,500
-17.89%
2023-05-12SaleSEA VII Management, LLC
6,240
0.0058%
$9.11
$56,846
-2.30%
2023-02-27SaleSEA VII Management, LLC
3M
2.7349%
$11.12
$33.36M
-15.26%
2022-11-07PurchaseKrantz Jason Ronalddirector
450,000
0.4297%
$11.54
$5.19M
-6.35%
2022-08-08SaleSpectrum Equity Associates VII, L.P.
1.02M
0.8868%
$22.75
$23.11M
-54.28%
2022-08-08SaleWinn David Randall
5,763
0.0053%
$24.02
$138,456
-54.28%
2022-05-10SaleSpectrum Equity Associates VII, L.P.
811
0.0008%
$16.52
$13,398
-17.75%
2022-05-10SaleHaywood Jeffrey Charles
18,315
0.0172%
$15.46
$283,150
-17.75%
2022-03-03PurchaseBooth Richard DouglasChief Financial Officer
2,374.17
0.0025%
$21.06
$50,000
-16.31%
2021-09-17SaleSEA VII Management, LLC
133,714
0.0783%
$25.31
$3.38M
-50.48%
Total: 11

Insider Historical Profitability

<0.0001%
Krantz Jason Ronalddirector
450000
0.4216%
$526,500.0010
<0.0001%
Booth Richard DouglasChief Financial Officer
63948
0.0599%
$74,819.3610
<0.0001%

DH Institutional Investors: Active Positions

Increased Positions55+30.05%3M+3.38%
Decreased Positions83-45.36%8M-8.64%
New Positions25New1MNew
Sold Out Positions28Sold Out3MSold Out
Total Postitions155-15.3%91M-5.25%

DH Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Advent International, L.P.$148,422.0060.67%62.49M00%2025-09-30
Goldman Sachs Group Inc$17,361.007.1%7.31M-1M-16.39%2025-09-30
Blackrock, Inc.$7,418.003.03%3.12M+7,812+0.25%2025-09-30
Vanguard Group Inc$6,581.002.69%2.77M-153,826-5.26%2025-09-30
Palisade Capital Management, Lp$5,089.002.08%2.14M-40,361-1.85%2025-09-30
Dimensional Fund Advisors Lp$4,924.002.01%2.07M+33,612+1.65%2025-09-30
D. E. Shaw & Co., Inc.$4,284.001.75%1.8M+394,860+28.02%2025-09-30
Morgan Stanley$3,325.001.36%1.4M-152,391-9.82%2025-09-30
Arrowstreet Capital, Limited Partnership$2,888.001.18%1.22M+127,055+11.67%2025-09-30
State Street Corp$2,785.001.14%1.17M-15,932-1.34%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.